Skip to main content

Table 4 Responders (PR or SD) and non-responders (PD) at 1 month after treatment

From: Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response

 

PR or SD (n = 32)

PD (n = 10)

WHO performance score (n)

 0

19

4

 1

12

5

 2

1

1

Extrahepatic disease at baseline (n)

 Yes

7

5

 No

25

5

Tumour load (% of the liver)

12%

22%

Liver dosea (Gy)

45

43

  1. Several patient characteristics of the patients defined as responders (PR or SD) and those defined as non-responders (PD). No statistically significant differences were observed
  2. PR partial response, SD stable disease, PD progressive disease, Gy gray
  3. aLiver dose was calculated as (administrated activity(MBq))/(treated liver volume(ml)) x 50